Children's Hospital of Eastern Ontario Research Institute Inc.: federal grants and contributions

Updated 11 October 2026 · Ottawa, ON · grants and contributions register · Ottawa South

Children's Hospital of Eastern Ontario Research Institute Inc.: federal grants and contributions: 7 agreements; $7.1M value; 5 departments; 5 programs.

Assay record ASY-CA-0LFJUJ403P · Cite as: Assay Systems, “Children's Hospital of Eastern Ontario Research Institute Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/children-s-hospital-of-eastern-ontario-research-institute-inc/

$
7agreements
$7.1Mvalue
5departments
5programs

Largest agreements

1003870$4.2Mvalue2023start2027end

To connect early-stage health innovations emerging from Eastern Ontario with product-focused companies delivering health solutions for youth to elderly populations.

2122-HQ-000064$2.0Mvalue2021start2026end

Not a Project (Mandated or Core Funding)

1920-HQ-000104$783Kvalue2019start2023end

Not a Project (Mandated or Core Funding)

CSJ 2022 - CHEO Research Institute (Ottawa South)$105Kvalue2022start2022end

Through the application of national and local priorities, the CSJ program seeks to provide youth, particularly those who face barriers to employment with access to work opportunities. Funded employers must demonstrate that they are providing quality work experiences for youth that provide opportunities to develop and improve their skills.

CSJ 2024 - Children's Hospital of Eastern Ontario Research Institute Inc. (Ottawa South)$26.8Kvalue2024start2024end

Through the application of national and local priorities, the CSJ program seeks to provide youth, particularly those who face barriers to employment with access to work opportunities. Funded employers must demonstrate that they are providing quality work experiences for youth that provide opportunities to develop and improve their skills.

Improved treatment options for children with Dravet syndrome$25.0Kvalue2019start2020end

Dravet Syndrome (DS) is a treatment-resistant Early-onset Infantile Epileptic Encephalopathy, severely impairing development. Identification and characterization of underlying SCN1A mutations will dictate drug screening strategies, utilizing a CHEO-curated library of blood-brain-penetrant FDA-approved drugs. This bench-to-bedside collaboration (NRC/CHEO) will establish a translational pipeline towards personalized precision medicine for children with DS.

2122-HQ-000022$11.8Kvalue2021start2022end

Not a Project (Mandated or Core Funding)

Departments

Federal Economic Development Agency for Southern Ontario1agreements$4.2Mvalue1programs
Health Canada2agreements$2.8Mvalue1programs
  • Canadian Health Systems and Programs

All grants from Health Canada

Employment and Social Development Canada2agreements$132Kvalue1programs
National Research Council Canada1agreements$25.0Kvalue1programs
  • Collaborative Science, Technology and Innovation Program – Ideation Fund

All grants from National Research Council Canada

Indigenous Services Canada1agreements$11.8Kvalue1programs

Years

20241agreements$26.8Kvalue1programs
  • Youth - Canada Summer Jobs
20231agreements$4.2Mvalue1programs
  • Regional Innovation Ecosystem (RIE)
20221agreements$105Kvalue1programs
  • Youth - Canada Summer Jobs
20212agreements$2.0Mvalue2programs
  • Canadian Health Systems and Programs
  • Public Health Protection
20192agreements$808Kvalue2programs
  • Canadian Health Systems and Programs
  • Collaborative Science, Technology and Innovation Program – Ideation Fund

Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.